Podcast

What patients need to know about cataract surgery

Author(s):

Uday Devgan, MD, FACS,Alex Delaney-Gesing

Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.

Listen to more EyePod episodes here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting, Seth Pantanelli, MD, speaks about the EyHance and enVista IOLs. Dr. Pantanelli is a professor of ophthalmology at Penn State College of Medicine in Hershey, Pennsylvania.
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
Related Content
VivaVision Biotech receives positive preliminary comments from FDA on development of VVN461LD
June 10th 2025

VivaVision Biotech receives positive preliminary comments from FDA on development of VVN461LD

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: AdobeStock/RFBSIP) The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucoma
June 4th 2025

The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucoma

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%
June 2nd 2025

Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%

CCS 2025: Managing laser corneal refractive surgery and implantable collamer lens based procedures
June 1st 2025

CCS 2025: Managing laser corneal refractive surgery and implantable collamer lens based procedures

© 2025 MJH Life Sciences

All rights reserved.